Biodesix to Acquire Oncimmune Operations, Lung Cancer Test in US - 360Dx
Biodesix to Acquire Oncimmune Operations, Lung Cancer Test in US 360Dx
NEW YORK — Biodesix said today that it has signed an agreement to acquire Oncimmune's US operations and the US rights to the firm's blood-based incidental ...
Comments
Post a Comment